Two- and 3-Year Outcomes of the Childhood Arthritis and Rheumatology Research Alliance FROST Study of New-onset Systemic JIA Treatment

被引：0
|
作者：
Hahn, Timothy [1 ]
Tomlinson, George [2 ]
Kimura, Yukiko [3 ]
Del Gaizo, Vincent [4 ]
Valdes, Carlos [5 ]
Beukelman, Timothy [6 ]
机构：
[1] Penn State Childrens Hosp, Hershey, PA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Hackensack Meridian Sch Med, New York, NY USA
[4] Childhood Arthrit & Rheumatol Res Alliance CARRA, Whitehouse Stn, NJ USA
[5] Genentech Inc, Davie, FL USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0381
引用
收藏
页码：754 / 756
页数：3
相关论文
共 49 条
  • [41] Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study
    Wipff, Julien
    Coriat, Romain
    Masciocchi, Michela
    Caramaschi, Paola
    Derk, Chris T.
    Hachulla, Eric
    Riccieri, Valeria
    Mouthon, Luc
    Krasowska, Dorota
    Ananyeva, Lidia P.
    Kahan, Andre
    Matucci-Cerinic, Marco
    Chaussade, Stanislas
    Allanore, Yannick
    RHEUMATOLOGY, 2011, 50 (08) : 1440 - 1444
  • [42] Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study. (vol 73, 1910, 2024)
    Ong, M. S.
    Ringold, S.
    Kimura, Y.
    Schanberg, L. E.
    Tomlinson, G. A.
    Natter, M. D.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1572 - 1572
  • [43] Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure A 3-year follow-up observational study in a large Chinese hospital
    Liu, Chen
    Geng, Jin
    Ye, Xiao
    Yuan, Xiaochen
    Li, Aihua
    Zhang, Zhengang
    Xu, Biao
    Wang, Yingwei
    MEDICINE, 2018, 97 (39)
  • [44] Risk prediction of new-onset thrombocytopenia in patients with systemic lupus erythematosus: a multicenter prospective cohort study based on Chinese SLE treatment and research group (CSTAR) registry
    Yupei Zhang
    Nan Jiang
    Xinwang Duan
    Jian Xu
    Lijun Wu
    Wei Wei
    Weiguo Xiao
    Li Luo
    Zhenyu Jiang
    Yanhong Wang
    Jiuliang Zhao
    Qian Wang
    Xinping Tian
    Mengtao Li
    Xiaofeng Zeng
    Arthritis Research & Therapy, 26 (1)
  • [45] Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
    ter Haar, Nienke M.
    van Dijkhuizen, E. H. Pieter
    Swart, Joost F.
    van Royen-Kerkhof, Annet
    el Idrissi, Ayman
    Leek, Arjen P.
    de Jager, Wilco
    de Groot, Mark C. H.
    Haitjema, Saskia
    Holzinger, Dirk
    Foell, Dirk
    van Loosdregt, Jorg
    Wulffraat, Nico M.
    de Roock, Sytze
    Vastert, Sebastiaan J.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1163 - 1173
  • [46] Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study
    Wang, Chuan
    Wang, Lingshu
    Liang, Kai
    Yan, Fei
    Hou, Xinguo
    Liu, Fuqiang
    Chen, Li
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [47] Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
    Vastert, Sebastiaan J.
    de Jager, Wilco
    Noordman, Bo Jan
    Holzinger, Dirk
    Kuis, Wietse
    Prakken, Berent J.
    Wulffraat, Nico M.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (04) : 1034 - 1043
  • [48] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana V.
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Sharaf, Mohamed
    Theander, Elke
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [49] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Laure Gossec
    Stefan Siebert
    Paul Bergmans
    Kurt de Vlam
    Elisa Gremese
    Beatríz Joven-Ibáñez
    Tatiana V. Korotaeva
    Frederic Lavie
    Wim Noël
    Michael T. Nurmohamed
    Petros P. Sfikakis
    Mohamed Sharaf
    Elke Theander
    Josef S. Smolen
    Arthritis Research & Therapy, 25
12345